IDEX Corporation's results for Q3 2026 (quarter ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-10-28. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.
At a glance
| Item | Value |
|---|---|
| Revenue (GAAP) | $952 million (+8.3% vs a year earlier) |
| Diluted EPS (GAAP) | $1.95 |
| Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs) | $2.33 |
| Full-year guidance | Raised |
Guidance
IDEX raised 2026 organic sales growth to 6.5%–6.8% (from 5%–6%) and adjusted EPS to $8.91–$8.96 (from $8.70–$8.85).
Why this label: Organic sales growth 6.5-6.8% 'up from previous guidance of 5% to 6%'; adjusted EPS $8.91-8.96 up from $8.70-8.85.
| Metric | Period | New | Prior (as stated in the release) |
|---|---|---|---|
| organic sales growth | FY2026 | 6.5%–6.8% | 5%–6% |
| adjusted diluted EPS | FY2026 | $8.91–$8.96 | $8.70–$8.85 |
From the release
Revenue: "Net sales · 951.7 · 878.7 · 73.0"
Earnings per share: "Reported diluted EPS of $1.95 and record adjusted diluted EPS of $2.33 both increased 15%"
organic sales growth: "Full year organic sales projected to increase 6.5% to 6.8% over the prior year, up from previous guidance of 5% to 6%"
adjusted diluted EPS: "Full year adjusted diluted EPS of $8.91 to $8.96, up approximately 12% year-over-year at midpoint, up from previous guidance of $8.70 to $8.85"
Quotes are copied from the filing; in table rows, cell borders are shown as “·”.
Key fact: Raised 2026 adjusted EPS guidance to $8.91–$8.96; Q3 orders rose 13%.
Source
IDEX Corporation earnings release (SEC filing), accession 0000832101-26-000026, filed 2026-10-28.
Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.